Competitive landscape
Drugs aimed at the same indication, from approved to preclinical.
13 drugs for “Melanoma”
Approved 2
- CemiplimabREGENERON PHARMACEUTICALS, INC.Melanoma
- TebentafuspImmunocore Holdings plcAdvanced Melanoma
Phase 3 9
- BrenetafuspImmunocore Holdings plcAdvanced Melanoma
- DarovasertibIDEAYA Biosciences, Inc.Uveal Melanoma
- FianlimabREGENERON PHARMACEUTICALS, INC.Melanoma
- Intismeran autogeneMerck & Co., Inc.Melanoma
- LGX818PFIZER INCMelanoma
- MEK162PFIZER INCMelanoma
- NaporafenibErasca, Inc.Advanced or Metastatic NRAS-mutant Melanoma
- Nivolumab andBRISTOL MYERS SQUIBB COMelanoma
- NKTR-214BRISTOL MYERS SQUIBB COMelanoma
Phase 2/3 2
Drugs whose recorded indications name this term, by development stage. Indications come from registries and labels, so a drug can appear under related terms.